Amgen Inc., US0311621009

Amgen opens the week with upcoming catalysts, shares on Nasdaq

22.06.2026 - 20:13:21 | ad-hoc-news.de

Amgen starts the week with the July earnings window and pipeline milestones in view. Nasdaq trade and recent market data frame the setup for investors.

Amgen Inc., US0311621009
Amgen Inc., US0311621009

By Mark Bergmann, Earnings & Calendar desk. Reviewed prior to publication on 2026-06-22, 20:12.

Amgen (US0311621009) opens the week with a clear calendar focus on Nasdaq. Ad hoc news says investors are watching the pipeline milestones and the next quarterly numbers.

What the calendar shows

The company’s next firm date in market calendars is the second-quarter 2026 earnings release, which market data providers expect in late July. The ad hoc news outlook cites that timing and places the stock on watch for clinical updates as well.

Recent market data put Amgen shares at 341.67 dollars on 2026-06-22 at 09:19:46, according to FinancialData.net. MarketBeat also showed 344.26 dollars at 01:50 PM Eastern, with the stock up 1.97 percent on the day in that feed.

Consensus and peers

For a broader market read, Amgen sits in the U.S. biotech group alongside names such as Gilead Sciences and Biogen on Nasdaq. That peer set matters because large-cap biotech often trades on pipeline visibility, late-stage trial data, and the timing of earnings calls.

Simple Wall St describes Amgen as a company that discovers, develops, manufactures, and delivers human therapeutics worldwide. Reuters or a major bank update would usually sharpen that picture further, but the live market angle here already comes from the earnings calendar and the Nasdaq quote.

Go deeper

All news and analysis on Amgen shares

The next earnings window and the current Nasdaq quote are the two anchors investors can track today.

What Amgen sells

Amgen’s product base includes biologic medicines such as Enbrel, Repatha, and Otezla. Those therapies anchor the company’s revenue model in chronic and specialty-care treatment rather than one-off consumer sales.

Nasdaq quote today

The Amgen shares (US0311621009) trade on Nasdaq at 341.67 dollars as of 2026-06-22 09:19:46.

Key data on Amgen shares

  • Company: Amgen Inc.
  • ISIN: US0311621009
  • Ticker: AMGN
  • Trading venue: Nasdaq
  • Price (as of 2026-06-22 09:19:46): 341.67 USD
  • Market cap: 183.31 billion USD (as of 2026-06-22)
  • Sector / industry: Biotechnology
  • Index membership: S&P 500

More on Amgen shares in social media

Disclaimer: This article is for information only and does not constitute investment advice.

en | US0311621009 | AMGEN INC. | boerse | 69605346 | bgmi